Looking back, investing ten thousand dollars in Novanta stock a decade ago seems like a masterstroke. That sum would now be worth over eighty five thousand dollars. The same investment in the S&P 500 would have grown to roughly thirty six thousand dollars. The math makes the decision look easy. The real challenge was not picking the stock, however. It was holding it.
The price of a single share tells you where the market values a company at one moment. It says nothing about the journey to get there. For Novanta shareholders, that journey was a volatile one. The stock fell by twenty percent or more from a prior closing high six times in that ten year span. Four of those declines exceeded thirty percent. Each of those drops was a distinct test of conviction.
Consider the most recent and most severe test. From its peak in July 2024 to its trough in November 2025, Novanta’s share price collapsed by 46.7 percent. During that same sixteen month period, the broader S&P 500 index gained over fifteen percent. Shareholders could not point to a weak market. They had to look squarely at Novanta. The worst single day came on November 6, 2025, when the stock plunged 19 percent on news of a five hundred fifty million dollar equity offering.
Imagine you held the shares at that July 2024 peak. For over a year, you watched the value of your investment erode, month after month, with no clear sign of a bottom. Even now, nearly two and a half years later, the stock has yet to close above that former high. This is the emotional reality of holding a growth stock. The five previous pullbacks each ended with the stock recovering to new highs, the slowest taking about a year. But sitting in the middle of a steep decline, that historical fact offers little comfort. You simply do not know if this time is different.
This leads to a critical question. Was something fundamentally broken with Novanta’s business during this deep fall? The financial statements suggest otherwise. At the November 2025 low, the company’s annual revenue was actually 6.7 percent higher than it had been at the July 2024 stock price peak. Its operating margin had only slipped modestly, from 13.0 percent to 12.4 percent. This pattern repeated from an earlier selloff between late 2021 and mid 2022, when revenue grew over fourteen percent even as the share price fell.
Novanta is a critical supplier of components for medical devices and advanced industrial automation. Its business model is built on providing essential parts for other companies’ complex products. Throughout the steepest decline, its reported revenue kept climbing. This disconnect is a powerful lesson. A stock price can detach from the underlying business for a surprisingly long time, moving in either direction. Think of Tesla, which still commands a trillion dollar plus valuation despite two consecutive years of declining vehicle deliveries. The market’s mood and mechanics often diverge from the numbers on an income statement.
The cost of failing this test of conviction is steep. Since that November 2025 low, Novanta stock has rallied 52.4 percent. An investor who sold at the bottom missed that entire move. Even after that recovery, the shares remain 18.8 percent below their old high. Those six harrowing declines were the admission price for the stock’s spectacular ten year return. Only those who held through every single one of them collected the full reward. The next time a stock in your portfolio suffers a deep fall, your first move should be to check the company’s revenue line. In Novanta’s deepest fall, the business was not collapsing. The stock was.
This story is not just about Novanta. Your goal is long term wealth, not loyalty to a single ticker symbol. Wealth is built by owning the companies that consistently outperform, the leaders in their fields. Sometimes, those leaders are in the same industry as a company you already own. Over the five years leading to October 2026, while Novanta’s stock fell 12.4 percent, Keysight Technologies gained 83 percent and Impinj soared 162 percent. These are Novanta’s peers.
- Novanta stock rallied 52.4 percent since November 2025 low
- Investor who sold at the bottom missed entire move
- Shares remain 18.8 percent below old high
- Six declines were admission price for ten year return
- Check company’s revenue line during a deep fall
- Wealth is built by owning outperforming companies
Finding these consistent outperformers requires constant comparison across the entire market. It demands looking beyond a single holding to see which companies are pulling ahead. This is the rationale behind a structured, multi stock portfolio focused on quality. The Trefis High Quality Portfolio, for example, holds thirty such companies in equal weight. Since its start in September 2020, it has returned more than 105 percent, outpacing a blended benchmark of large, mid, and small cap indexes. The lesson from Novanta’s rollercoaster ride is clear. Patience is vital, but so is perspective. Your job is to hold through the temporary storms when the business is sound, and to have the clarity to recognize when a better opportunity has quietly taken the lead.
